Health
MS lifeline as drug that can slow disease listed – Chinchilla News
Patients who develop the second progressive stage of Multiple Sclerosis will only have to pay $41 for a drug that helps slow down the disease.
Patients living with multiple sclerosis have been granted a lifeline with the federal government listing a drug that can help slow down the progression of the disease.
The move will mean all patients who might benefit from “Mayzent” will only have to pay $41 per script rather than the estimated $25,000 yearly cost.
Multiple sclerosis, known as MS, is the most commonly acquired neurological disease in younger adults with more than 25,600 Australians living with the condition.
The average age of diagnosis…
-
Noosa News24 hours agoCar discovered in search for missing mother Tayla Spies last seen in rural Queensland two months ago
-
Business23 hours agoHow your ASX shares may be impacted by US tariffs
-
Noosa News23 hours agoSunshine Coast police saturate roads and beaches this Easter
-
Noosa News21 hours agoWith The Horrors, Clown Core, a Car Crash and an Artist Inside an Hourglass on Its 2025 Lineup, Dark Mofo Is Definitely Back